Pandemic Still Putting Pressure On Novartis Oncology Portfolio

CEO Concerned About Diagnosis Delays

 
• By Kevin Grogan
  
COVID-19 shadow hanging over Novartis cancer drug sales • Source: Archive
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapy Areas